Rodolfo Hanigan, Author at Stocks Today

ADA is trading around $0.17, a stone’s throw from its lowest level in years, while the Cardano ecosystem grapples with...

BioNTech at a Crossroads: FDA Filing Looms as Phase 3 Pipeline Takes Shape

The shares trade at €77 — roughly 27% below the 52-week high and below both their 50-day and 200-day moving...

Touchscreens and Lift Platforms Are Reshaping How German Industry Weighs Its Goods

In pharmaceutical and food production, the old routine of scrubbing under a scale after every shift is disappearing. New platform...

Microsoft’s Cost-Cutting AI Push Collides With a $190 Billion Bet

Satya Nadella has sent an unusual message to Microsoft’s workforce: stop burning expensive frontier models on mundane tasks. The directive,...

Green Bridge Metals’ Multi-Year Countdown Begins as Drilling Targets Critical Mineral Resources in Minnesota

The energy transition has cast a long shadow over the US supply chain, but for junior explorer Green Bridge Metals,...

Heidelberg Druck’s Radical Overhaul: Production Moves East, Defense Venture Takes Shape Amid Cash Flow Strain

The market is taking notice of Heidelberger Druckmaschinen’s gamble. The SDax-listed printing press manufacturer saw its shares climb 4.04% on...

Ocugen’s Mutation-Agnostic Gene Therapy Edges Toward FDA Filing as $130M Financing Secures Runway to 2028

Ocugen is betting that a single therapeutic can rewrite the rules for treating inherited retinal diseases. Its lead candidate, OCU400,...

BYD’s Dash for Global Supremacy Encounters Pentagon Hurdles and Home Market Headwinds

The gap between BYD’s ambitions and the market’s mood is widening. Chairman Wang Chuanfu has laid out a five-year plan...

Redwood AI’s Grants, Patents, and Police Partnerships Can’t Prevent 11% OTC Rout

Redwood AI has multiplied its chemical reaction database fivefold to 21 million training examples and filed a new patent, yet...

Xiaomi’s Premium Push Collides with Margins as Stock Sinks to New Low